dallas semaglutide lawsuit law firm in semaglutide constipation attorney in dallas Ozempic Lawsuit-tarwiahtravel semaglutide class action in dallas

PMID 10025398

Semaglutide is also available as Rybelsus 3 mg and 7 mg tablets

Semaglutide (aka Ozempic or Wegovy) has become ubiquitous because of established benefits in diabetes and obesity but SELECT showed that the drug should be considered in those who are obese with established atherosclerotic CV disease (ASCVD.) In March of 2024 the FDA approved a new indication for Wegovy based on the SELECT trial to reduce the risk of CV death, stroke, and heart attack in adults with cardiovascular disease and either obese or overweight My Thoughts on Semaglutide for Secondary Prevention After looking in detail at SELECT I realized that it does not apply to most patients in my practice

On a call with BI, Nestl's senior manager for health and wellness, Marlene Schmidt, cited Morgan Stanley's recent report predicting that by 2035, roughly 7% of the US population will be on a weight loss drug